Conexeu Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023
Net Income	-3.92	-0.47	-0.04
Depreciation & Amortization	0.02	-	-
Stock-Based Compensation	2.18	0.01	0
Other Adjustments	-0.04	-0.18	-
Changes in Accounts Payable	0.09	0.45	0.03
Changes in Accrued Expenses	0.08	-	-
Changes in Income Taxes Payable	-0	-	-
Changes in Other Operating Activities	-0.06	-0.03	-
Operating Cash Flow	-1.67	-0.23	-0
Capital Expenditures	-0.02	-	-
Other Investing Activities	-0.07	-	-
Investing Cash Flow	-0.09	-	-
Long-Term Debt Repaid	-0.09	-	-
Net Long-Term Debt Issued (Repaid)	-0.09	-	-
Issuance of Common Stock	6.42	0.53	0
Net Common Stock Issued (Repurchased)	6.42	0.53	0
Other Financing Activities	-0.05	0	0
Financing Cash Flow	6.28	0.53	0
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0	0.01	-
Net Cash Flow	4.52	0.31	0

Updated Apr 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q